IP vs RNAC
International Paper (IP) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
IP currently screens at market cap $26.62B and trailing P/E 43.1. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the IP and RNAC stock pages for the full models.
Not investment advice.